Editorial
Extended lobectomy—how minimally invasive can we go?
Translational Lung Cancer Research
2024;
13
(5)
:961-964
.
(31 May 2024)
Original Article
Contribution of crosstalk of mesothelial and tumoral epithelial cells in pleural metastasis of lung cancer
Translational Lung Cancer Research
2024;
13
(5)
:965-985
.
(31 May 2024)
Comprehensive analysis of next generation sequencing and ARMS-PCR for detecting EGFR exon 20 insertion (ex20ins) mutations in Chinese non-small cell lung cancer patients
Translational Lung Cancer Research
2024;
13
(5)
:986-997
.
(31 May 2024)
Development of a predictive model to predict postoperative bone metastasis in pathological I–II non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(5)
:998-1009
.
(31 May 2024)
GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(5)
:1010-1031
.
(31 May 2024)
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer
Translational Lung Cancer Research
2024;
13
(5)
:1032-1046
.
(31 May 2024)
Race, age at diagnosis and histological characteristics of lung cancer in never-smokers (LCINS) and ever-smokers in low-dose computed tomography (LDCT) screening: a systematic review and meta-analysis
Translational Lung Cancer Research
2024;
13
(5)
:1047-1060
.
(31 May 2024)
Pleural carbohydrate antigen 50 and malignant pleural effusion: a prospective, double-blind diagnostic accuracy test
Translational Lung Cancer Research
2024;
13
(5)
:1061-1068
.
(31 May 2024)
Clinical predictors of severe radiation pneumonitis in patients undergoing thoracic radiotherapy for lung cancer
Translational Lung Cancer Research
2024;
13
(5)
:1069-1083
.
(31 May 2024)
Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma
Translational Lung Cancer Research
2024;
13
(5)
:1084-1100
.
(31 May 2024)
Contrast-enhanced CT and PET-CT characteristics of primary tracheal lymphoepithelioma-like carcinoma: case series
Translational Lung Cancer Research
2024;
13
(5)
:1101-1109
.
(31 May 2024)
Brief Report
Outcomes of initial therapy for synchronous brain metastases from small cell lung cancer: a single-institution retrospective analysis
Translational Lung Cancer Research
2024;
13
(5)
:1110-1120
.
(31 May 2024)
Review Article
Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications
Translational Lung Cancer Research
2024;
13
(5)
:1121-1136
.
(31 May 2024)
Potential predictors of the pathologic response after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a narrative review
Translational Lung Cancer Research
2024;
13
(5)
:1137-1149
.
(31 May 2024)
Case Report: iMDT Corner
A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring EML4-ALK rearrangement
Translational Lung Cancer Research
2024;
13
(5)
:1150-1162
.
(31 May 2024)
Case Report
A novel HLA-DQB2::MET gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case report
Translational Lung Cancer Research
2024;
13
(5)
:1163-1168
.
(31 May 2024)
Editorial Commentary
Genetic diversity in small cell lung carcinoma
Translational Lung Cancer Research
2024;
13
(5)
:1169-1172
.
(31 May 2024)
Unravelling the puzzle of immunotherapeutic efficacy in lung cancer
Translational Lung Cancer Research
2024;
13
(5)
:1173-1176
.
(31 May 2024)
Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma
Translational Lung Cancer Research
2024;
13
(5)
:1177-1182
.
(31 May 2024)
Synergistic effect of canakinumab with epidermal growth factor receptor tyrosine kinase inhibitors versus with chemotherapy for non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(5)
:1183-1184
.
(31 May 2024)
